A Perspective, Multicenter, Open-label and Observational Trial for Unrelated Umbilical Cord Blood Stem Cell Microtransplantation Combined With Azacitidine Based Treatment for Advanced MDS,CMML-2 and Secondary AML.
Latest Information Update: 20 Oct 2022
At a glance
- Drugs Azacitidine (Primary) ; Omacetaxine mepesuccinate (Primary) ; Venetoclax (Primary)
- Indications Acute myeloid leukaemia; Chronic myelomonocytic leukaemia; Myelodysplastic syndromes
- Focus Therapeutic Use
Most Recent Events
- 20 Oct 2022 New trial record